Purpose: Erectile dysfunction (ED) remains a major complication from cavernous nerve injury during radical prostatectomy. Recently, stem cell treatment for ED has been widely reported. This study was conducted to investigate the availability, differentiation into functional cells, and potential of human muscle-derived stem cells (hMDSCs) and human adipose-derived stem cells (hADSCs) for ED treatment.
INTRODUCTION
Erectile dysfunction (ED) remains a common cause of significant postoperative morbidity in patients undergoing radical therapies for prostate cancers or other pelvic malignancies, because the cavernous nerve can be inadvertently axotomized, lacerated, or stretched at the time of surgery. Although techniques such as nerve-sparing radical prostatectomy, nerve grafting, and robotic-assisted radical prostatectomy have been developed in which the cavernous nerve is largely preserved, postoperatively, patients still face a high incidence of ED. In recent years, stem cell therapy has evolved as a potential therapy in the prevention of ED following cavernous nerve injury. The multilineage differentiation potential of stem cells can contribute to regenerate the damaged cavernous nerve, thereby providing an autologous and curative therapeutic option [1] .
Although bone marrow cells have the ability to differentiate into neurons, limitations hinder the widespread application of these cells [2, 3] . Among the various stem cells, human muscle-derived stem cells (hMDSCs) and human-adipose tissue derived stem cells (hADSCs) have great potential in stem cell therapy because of their abundance, ease of isolation, and low immunogenicity [4] . In ad-dition, hMDSCs and hADSCs have a considerable capacity for self-renewal and can differentiate into neural lineages [5] [6] [7] [8] [9] . Although many studies on the neurogenic trans-differentiation of hMDSCs and hADSCs have been conducted, no in vitro studies are available for comparison of the neurogenic capacity of these cells. In this study, therefore, we compared the neuronal differentiation capacity of hMDSCs with that of hADSCs in vitro.
MATERIALS AND METHODS

Cell isolation Human adipose-derived stem cells
Human adipose tissues were obtained by simple liposuction from the abdominal subcutaneous fat of donors. Subcutaneous adipose tissues were washed with phosphate-buffered saline (PBS) and digested with 1 mg/ml collagenase under gentle agitation for 60 minutes at 37 o C. Next, the digested tissues were filtered through a 100 μm nylon mesh in order to remove cellular debris and centrifuged at 1,500 rpm for 5 min to obtain a pellet. The pellet was re-suspended in RCME (RNL Bio, Seoul, Korea) or DMEM containing 10% fetal bovine serum (FBS). The cell suspension was re-centrifuged at 1,500 rpm for 5 minutes. The supernatant was discarded and the cell pellet was collected. The cell fraction was cultured overnight at 37℃ in 5% CO2 in RCME or DMEM. Adhesion of cells was checked under a microscope the next day. The procedure for preparation of hADSCs was performed under GMP conditions in the Stem Cell Research Center of RNL Bio. Human muscle-derived stem cells Using scalpels, hMDSCs isolated from the rectus muscles of humans were removed and minced into a coarse slurry. Muscle tissues were enzymatically dissociated in collagenase type XI (Sigma, St. Louis, MO, USA), dispase (Invitrogen, Carlsbad, CA, USA), and trypsin-EDTA (Invitrogen). After physical and enzymatic dissociations, muscle-derived cells were centrifuged and re-suspended in proliferation medium (containing DMEM [Gibco, Grand Island, NY, USA], 10% horse serum, 10% FBS, 1% chick embryo extract, and 1% penicillin-streptomycin). For isolation of SMNPs, cells were plated in collagen-coated flasks (PP1). After 2 hours, cells non-adherent in PP1 were transferred into the next flasks (PP2) and incubated for 16 hours. No adherent cells were observed in PP3; therefore, the serial transfer of non-adherent cells was terminated at this point. During cultivation, two morphologically different cell populations were identified. These were fibroblast-like cells and round-shaped cells.
PP1 flasks initially contained a high proportion of fibroblast-like cells. PP2 and PP3 flasks contained approximately 30%, 10%, and ＜1% of fibroblast-like cells, respectively. Further purification of weakly adherent cells (primarily round-shaped cells) was performed on cells adherent in PP2 and PP3 flasks. Cells were trypsinized for 3 min, after which suspended cells from PP2 and PP3 flasks were combined and re-plated in a fresh flask. As these cells proliferated in proliferation medium for 3 to 4 days, the cells formed additional colonies.
Neural induction
Both hMDSCs and hADSCs (1x10 5 cells) were grown as adherent cultures in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin at 37 o C in 5% CO2. After 24 hours, cells were washed with PBS and plated in neurobasal media, 1% penicillin, and 50 μM/ml of forskolin and 1 μg/ml laminin, 20 ng/ml basic fibroblast growth factor (bFGF), and 20 ng/ml epidermal growth factor (EGF) with 2% FBS.
Immunocytochemistry
Both hMDSCs and hADSCs were placed and grown on poly-L-lysine-coated cover slips for 5 days. After 5 days, these cells were washed with PBS, fixed with 4% paraformaldehyde for 10 minutes at room temperature, washed with PBS again, and then permeabilized with 0.1% Triton-X 100. After washing twice with PBS, cells were blocked by incubation with 10% normal goat serum for 1 hour at room temperature. Nestin (1:100; Abcam, Combride, UK), β-tubulin III (Tuj1, 1:500; Abcam, Combride, UK), and GFAP (1:100; Abcam, Combride, UK) were then added. Primary antibodies were incubated overnight at 4 o C. After washing, the cells were treated with Alexa 488-conjugated goat anti-mouse antibody as a secondary antibody, followed by incubation at room temperature for 1 hour. Nuclei were stained with DAPI for cell counting, and the cells were observed under a fluorescence microscope.
Real-time polymerase chain reaction analysis
RNA was extracted from hMDSCs, differentiated hMDSCs (d-hMDSCs), hADSCs, and differentiated hADSCs (dhADSCs). Total RNA was prepared by using Trizol according to the manufacturer's protocol. First-strand cDNA was synthesized by using Oligo dT primer and Superscript II reverse transcriptase according to the manufacturer's instructions. Real-time polymerase chain reaction analysis (PCR) was performed by using RT SYBR Green/ROX qPCR Master Mix using the Real-time Thermal Cycler 
Western blot analysis
Protein was homogenized in ice-cold lysis buffer containing 20 mM Tris-Cl, pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 10 M leupeptin, 20 g/ml chymostatin, and 2 mM PMSF. Following centrifugation at 12,000 xg for 30 minutes at 4 o C, the supernatant was extracted and quantified by use of the bicinchoninic acid (BCA) protein assay kit (Pierce, Rockford, IL, USA) and then electrophoresed on an SDS-PAGE gel. After transfer to a nitrocellulose membrane, the membrane was blocked with 5% skim milk and then incubated with antibody against nestin (1:1,000; Abcam), β-tubulin III (1:1,000; Abcam), GFAP (1:1,000; Abcam), or β-actin, followed by incubation with the corresponding secondary antibody conjugated to horseradish peroxidase. The ECL method (Amersham, Arlington Heights, IL, USA) was used for development of protein bands.
Statistical analysis
Statistical analyses were performed by using the two-tailed Student's t-test. Data are expressed as the mean±SD, and p＜0.05 was considered statistically significant.
RESULTS
Morphologic changes after neural induction
hMDSCs and hADSCs were round in monolayer cultures before neural induction (Fig. 1a and i) . In immunohistochemical staining, hMDSCs and hMDSCs were strongly positive for neural stem cell marker (nestin), but weakly positive for neuronal marker (β-tubulin III) and glial marker (GFAP) (Fig. 1b-d and j-l) .
Following 5 days of neural induction, hMDSCs and hADSCs displayed a differentiated phenotype in morphology ( Fig. 1e and n) . Immunohistochemistry showed that nestin expression was decreased, and β-tubulin III and GFAP expression were increased (Fig. 1f-h and m-p) . There was no significant difference in nestin expression between d-hMDSCs and d-hADSCs; however, β-tubulin III and GFAP expression in d-hADSCs was increased compared with that in d-hMDSCs. According to cell morphology and staining, hADSCs had a higher phenotype and neurogenic potential than did hMDSCs.
Real-time polymerase chain reaction analysis
To dissect the neurogenic potential of hMDSCs and hADSCs at the molecular level, the mRNA levels of nestin, β-tubulin III, and GFAP were detected by real-time PCR, normalized to the housekeeping GAPDH. Nestin mRNA levels in d-hMDSCs and d-hADSCs were approximately 50% lower than the expression in hMDSCs and hADSCs, respectively. There was no significant difference in nestin mRNA expression between d-hMDSCs and d-hADSCs ( Fig. 2A) . However, β-tubulin III and GFAP mRNA expression in d-hADSCs was significantly higher than that in d-hMDSCs (Fig. 2B and 2C ).
Western blot analysis
We also investigated the protein expression of nestin, β-tubulin III, and GFAP in differentiated hMDSCs and hADSCs by Western blot analysis (Fig. 3A) . The protein expression of nestin, β-tubulin III, and GFAP before and after differentiation showed almost the same tendency with mRNA expression. Protein expression of nestin in the hMDSCs and hADSCs was significantly decreased after neuronal induction (Fig. 3B) . β-tubulin III and GFAP protein expression in d-hADSCs was significantly higher than that in d-hMDSCs (Fig. 3C and 3D) .
DISCUSSION
This study compared the neurogenic potential of hMDSCs and hADSCs by detecting several neuron cell markers. Our data suggest that differentiated hADSCs have higher neuronal/glial marker expression than do hMDSCs and thereby are more suitable for nerve regeneration.
The incidence of ED after radical prostatectomy by cavernous nerve injury remains high. Recently, stem cell treatment has been regarded as a potential treatment for ED [1, 4] . In recent years, tissue engineering strategies have combined living cells and scaffold materials for the development of biological substitutes that can restore tissue functions. Both natural and synthetic materials have been fabricated for transplantation of stem cells and their specific differentiation into muscles, bones, cartilage, and neuron-like cells. Studies have shown that hMDSCs and hADSCs can be induced into adipocytes, osteoblasts, chondrocytes, myocytes, hepatocytes, endotheliocytes [5] [6] [7] [8] [9] , and neuron-like cells [2, [10] [11] [12] [13] . The surface phenotype of hMDSCs and hADSCs is similar to that of bone marrow-derived stromal cells [2, 3] . Previous reports have indicated that neural differentiation of hMDSCs and hADSCs is achieved with different experimental protocols, including the use of chemical agents, such as forskolin [11, [14] [15] [16] [17] , laminin [11, 14, 18] , EGF, and bFGF [11, 14, 17, 19] . bFGF is known to generate neural precursor cells with a greater capacity for neuronal differentiation. EGF and neurotrophic factor are reported to restrict astrocyte lineages. Forskolin is a commonly used agent to increase the intracellular levels of cyclic adenosine monophosphate (cAMP) by activating the enzyme adenylyl cyclase. Laminin-stimulated levels of tyrosine hydroxylase of chromaffin cells were associated with their conversion to adrenergic sympathetic cells. Laminin has differential action in the proliferation, survival, and differentiation of cultured neuronal cells. Although forskolin, laminin, EGF, and bFGF enhanced neuron-like cell production, the results were greatly improved when the combination was added to the medium.
We succeeded in inducing the neural differentiation of hMDSCs and hADSCs by treatment with forskolin, laminin, b-FGF, and EGF. In the present study, the neural differentiation of hMDSCs and hADSCs was observed for several days. The neuronal phenotype at 5 days following neural induction was observed by staining for nestin-negative and β-tubulin III-and GFAP-positive. We found that d-hMDSCs and d-hADSCs displayed similar immunocytochemical changes following neural induction. hMDSCs and hADSCs grown under control conditions expressed low β-tubulin III and GFAP but detectable levels of nestin. After 5 days of neural induction, we detected strong staining for β-tubulin III as well as GFAP in d-hADSCs. Real-time PCR and Western blotting confirmed that the number of undifferentiated hMDSCs and hADSCs expressing cell type-specific markers was very low. Marker-positive cells showed a considerable increase with neural supplements. Neurons were observed in cultures when compared with that of nestin-negative and β-tubulin III-, GFAP-positive. Our results showed that differentiated muscle-or adipose-derived stem cells have morphological and phenotypic characteristics that are similar to those of neural cells. In this study, we confirmed that the ability of hADSCs to differentiate into neural cells was better than that of hMDSCs.
CONCLUSIONS
In summary, we have shown that both hMDSCs and hADSCs have morphological and phenotypic characteristics similar to those of neural cells. hADSCs have more neurogenic differentiation potential than do hMDSCs. Therefore, hADSCs seem to be an ideal alternative source of stem cells for cavernous nerve regeneration.
